Apricus Biosciences Presents Vitaros® Poster at the International Symposium on Prostate, Androgens and Men's Sexual Health
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
SAN DIEGO, 2013-06-21 09:00 CEST (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ('Apricus Bio' or the 'Company') (Nasdaq:APRI) (www.apricusbio.com) announced today that it will present a poster with results of an analysis of existing Phase 3 data for Vitaros(r), the Company's lead product candidate for the treatment of erectile dysfunction (ED), at the International Symposium on Prostate, Androgens and Men's Sexual Health. The Symposium is being convened jointly by the European Society of Sexual Medicine ('ESSM') and the International Society for Sexual Medicine ('ISSM'), and is taking place June 21-23, 2013 in Berlin, Germany.
Help employers find you! Check out all the jobs and post your resume.
SAN DIEGO, 2013-06-21 09:00 CEST (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ('Apricus Bio' or the 'Company') (Nasdaq:APRI) (www.apricusbio.com) announced today that it will present a poster with results of an analysis of existing Phase 3 data for Vitaros(r), the Company's lead product candidate for the treatment of erectile dysfunction (ED), at the International Symposium on Prostate, Androgens and Men's Sexual Health. The Symposium is being convened jointly by the European Society of Sexual Medicine ('ESSM') and the International Society for Sexual Medicine ('ISSM'), and is taking place June 21-23, 2013 in Berlin, Germany.
Help employers find you! Check out all the jobs and post your resume.